Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293332
Status:
TERMINATED
Last Update Posted:
2011-02-09
First Post:
2006-02-16
Brief Title:
Docetaxel Carboplatin and Bevacizumab in Treating Patients With Stage I Stage II or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
CDR0000455640
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California San Francisco
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Sarita Dubey MD
Old Organization:
UCSF
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |